Second Affiliated Hospital of Wenzhou Medical University: Colitis, Ulcerative trials

The registry lists 11 Colitis, Ulcerative studies with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative ColitisRecruitingNCT07726888
• Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.CompletedNCT07564895
• The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative ColitisCompletedNCT07398586Phase 4
• The Association Between TNFSF4 Polymorphism and CDCompletedNCT07263464
• An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese PatientsCompletedNCT06961435
• The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative ColitisCompletedNCT06873711
• the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative ColitisCompletedNCT06856031
• An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of VedolizumabCompletedNCT06855862
• Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative ColitisCompletedNCT05649462
• Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene PolymorphismStatus unknownNCT04309058Early Phase 1
• A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative ColitisCompletedNCT04276649